Literature DB >> 3322471

Histochemical study of lectin binding in neoplastic and non-neoplastic urothelium.

D E Neal1, R G Charlton, M K Bennett.   

Abstract

A histochemical study of lectin binding was performed to assess staining with lectins and, therefore, the expression of complex carbohydrates in human neoplastic urothelium. Forty-seven patients with transitional cell carcinoma of the bladder and six controls were studied. Cryostat sections were stained with a panel of 10 biotinylated lectins by means of the avidin-biotin-peroxidase technique. Sixteen tumours were also studied after conventional formalin fixation and paraffin embedding. In general, staining by lectins of tumours was more intense than staining of control urothelium and staining of tumours invading bladder muscle was greater than that of superficial tumours (both P less than 0.001). A small but statistically significant diminution of staining was observed after formalin fixation and paraffin embedding (P less than 0.05). Four lectins--Bandeiraea simplicifolia (P less than 0.01), Vicia villosa (P less than 0.01), peanut agglutinin (P less than 0.001) and soyabean agglutinin (P less than 0.001) stained invasive tumours more frequently than superficial tumours in frozen sections. Thus, increased binding of certain lectins was found in human transitional cell tumours and correlated with muscle invasion and poor differentiation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3322471     DOI: 10.1111/j.1464-410x.1987.tb05002.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  9 in total

1.  Chronic treatment with epidermal growth factor stimulates growth of the urinary tract in the rat.

Authors:  L Vinter-Jensen; M Smerup; P E Jørgensen; C O Juhl; T Orntoft; S S Poulsen; E Nexø
Journal:  Urol Res       Date:  1996

2.  Selective binding of lectins to normal and neoplastic urothelium in rat and mouse bladder carcinogenesis models.

Authors:  Daša Zupančič; Mateja Erdani Kreft; Rok Romih
Journal:  Protoplasma       Date:  2013-07-05       Impact factor: 3.356

3.  Lectins as Biomarkers of IC/BPS Disease: A Comparative Study of Glycosylation Patterns in Human Pathologic Urothelium and IC/BPS Experimental Models.

Authors:  Dominika Peskar; Tadeja Kuret; Jera Jeruc; Andreja Erman
Journal:  Diagnostics (Basel)       Date:  2022-04-25

4.  Biomimetic delivery strategies at the urothelium: targeted cytoinvasion in bladder cancer cells via lectin bioconjugates.

Authors:  Lukas Neutsch; Britta Eggenreich; Ela Herwig; Martina Marchetti-Deschmann; Günter Allmaier; Franz Gabor; Michael Wirth
Journal:  Pharm Res       Date:  2013-12-24       Impact factor: 4.200

5.  Chronic treatment with epidermal growth factor causes esophageal epithelial hyperplasia in pigs and rats.

Authors:  C O Juhl; L Vinter-Jensen; S S Poulsen; T F Orntoft; E Z Dajani
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

6.  Use of Aleuria alantia Lectin Affinity Chromatography to Enrich Candidate Biomarkers from the Urine of Patients with Bladder Cancer.

Authors:  Sarah R Ambrose; Naheema S Gordon; James C Goldsmith; Wenbin Wei; Maurice P Zeegers; Nicholas D James; Margaret A Knowles; Richard T Bryan; Douglas G Ward
Journal:  Proteomes       Date:  2015-09-03

7.  Combined lectin- and immuno-histochemistry (CLIH) for applications in cell biology and cancer diagnosis: Analysis of human urothelial carcinomas.

Authors:  Daša Zupančič; Mateja Erdani Kreft; Igor Sterle; Rok Romih
Journal:  Eur J Histochem       Date:  2020-07-01       Impact factor: 3.188

8.  High mannose level in bladder cancer enhances type 1 fimbria-mediated attachment of uropathogenic E. coli.

Authors:  Naseem Maalouf; Chamutal Gur; Vladimir Yutkin; Viviana Scaiewicz; Ofer Mandelboim; Gilad Bachrach
Journal:  Front Cell Infect Microbiol       Date:  2022-08-31       Impact factor: 6.073

9.  Clonal analysis of a bladder cancer cell line: an experimental model of tumour heterogeneity.

Authors:  J L Brown; P J Russell; J Philips; J Wotherspoon; D Raghavan
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.